Dr. Reddy’s Laboratories is a leading global pharmaceutical company headquartered in Hyderabad, India, committed to making affordable and innovative medicines accessible worldwide. Established in 1984 by Dr. Kallam Anji Reddy, the company develops, manufactures, and markets generic medicines, biosimilars, active pharmaceutical ingredients (APIs), proprietary products, and over-the-counter healthcare solutions. Dr. Reddy’s operates across more than 70 countries, with strong commercial operations in North America, Europe, India, and emerging markets. The company has earned recognition for its expertise in complex generics, injectables, oncology, and biosimilars while continuously investing in research and digital healthcare initiatives. Its manufacturing facilities comply with international quality standards, supporting a diversified global supply chain. Through strategic partnerships, product innovation, and a patient-centric approach, Dr. Reddy’s continues to strengthen its position as one of India’s largest pharmaceutical exporters and a trusted healthcare partner serving millions of patients worldwide.
NSE: DRREDDY | BSE: 500124
Hyderabad, Telangana, India
~26,000 employees
